Jove
Visualize
Contact Us

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Ankle Joint01:10

Ankle Joint

The ankle is formed by the talocrural joint (crural = leg). It consists of the articulations between the talus bone of the foot and the distal ends of the tibia and fibula of the leg. The superior aspect of the talus bone is square-shaped and has three areas of articulation. The top of the talus articulates with the inferior tibia. This is the portion of the ankle joint that carries the body weight between the leg and foot. The sides of the talus are firmly held in position by the articulations...
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.

Annals of the rheumatic diseases·2024
Same author

One-year outcomes of same-day-discharge robot-assisted radical prostatectomy.

BJU international·2024
Same author

Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.

World journal of urology·2024
Same author

How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group.

BJU international·2024
Same author

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].

European urology·2024
Same author

Complications of immuno-oncology care: what urologist should know.

BJU international·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile idiopathic arthritis.

Berent Prakken1, Salvatore Albani, Alberto Martini

  • 1Centre for Molecular and Cellular Intervention, Department of Paediatrics, University Medical Centre Utrecht, Netherlands.

Lancet (London, England)
|June 21, 2011
PubMed
Summary

Recent advances in juvenile idiopathic arthritis research have improved disease classification and treatment. New genetic and immunologic insights are guiding personalized therapies for this complex childhood arthritis.

Related Experiment Videos

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Juvenile idiopathic arthritis (JIA) is a diverse group of childhood-onset arthritis conditions of unknown etiology.
  • Recent research has significantly advanced understanding and management of JIA.
  • Key areas of progress include disease classification, treatment strategies, and underlying immune mechanisms.

Purpose of the Study:

  • To summarize pivotal research in JIA over the past five years.
  • To highlight advancements in understanding disease heterogeneity and immune pathways.
  • To discuss the implications of new findings for classification and personalized treatment.

Main Methods:

  • Review of gene expression profiling studies to identify immune mechanisms in JIA subtypes.
  • Immunological studies investigating systemic JIA as an autoinflammatory disease.
  • Analysis of T-helper cell balance and regulatory T cells in synovial inflammation.
  • Evaluation of soluble biomarkers, such as S100 proteins, for treatment guidance.

Main Results:

  • Gene expression profiling revealed distinct immune mechanisms across JIA subtypes, aiding reclassification.
  • Systemic JIA was identified as an acquired autoinflammatory disease, leading to successful IL-1 and IL-6 blockade therapies.
  • Synovial inflammation in other JIA forms is linked to an imbalance between pro-inflammatory T-helper-17 cells and anti-inflammatory regulatory T cells.
  • S100 proteins emerged as potential biomarkers for guiding individual patient treatment.

Conclusions:

  • New developments in genetics, immunology, and imaging are crucial for refining JIA definition and classification.
  • Targeted therapies, including cytokine blockade, show promise for specific JIA subtypes.
  • Understanding immune dysregulation offers pathways for personalized treatment strategies in JIA.
  • Biomarker discovery, like S100 proteins, will enhance individualized therapeutic approaches for children with JIA.